Working… Menu

A Phase 2 Study of CIN-102 in Adults With Idiopathic and Diabetic Gastroparesis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT04026997
Recruitment Status : Completed
First Posted : July 19, 2019
Last Update Posted : July 21, 2021
Information provided by (Responsible Party):
CinDome Pharma, Inc.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : December 17, 2020
Actual Study Completion Date : December 17, 2020
Certification/Extension First Submitted : July 16, 2021